ArticleClinical and translational allergy2021

Prospective Italian real-world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports.

Laura Pini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.